European Case Law Identifier: | ECLI:EP:BA:2015:T102111.20150602 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 02 June 2015 | ||||||||
Case number: | T 1021/11 | ||||||||
Application number: | 06850366.3 | ||||||||
IPC class: | A61K 39/12 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs | ||||||||
Applicant name: | Boehringer Ingelheim Vetmedica, Inc. | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Main request: Two independent claims for the same medical use; one claim under the provisions of EPC 1973 invoking legal fiction in G 5/83 and other claim under the provisions of Article 54(5) EPC 2000 (yes) Main request: allowable (yes) |
||||||||
Catchwords: |
see points 34 to 49 |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t111021eu1.html
Date retrieved: 17 May 2021